CXCL9 and neoplasm: The results demonstrated significantly higher mRNA expression of IFN-γ, TNF-α, IL-2, IL-12a, CXCL9, and CXCL10 in the tumor tissue of the PD-L1-KO/ZG16 overexpression group compared to the control group (Figure 6C).